Cannabis Cannabinoid Res. 2016 Jan 1;1(1):38-43. doi: 10.1089/can.2015.0010. eCollection 2016.
Abstract
Many patients with chronic medical illnesses use cannabinoids. There are two FDA-approved cannabinoid products, whereas medical marijuana purchased at legal dispensaries is not FDA regulated and may contain uncertain concentrations of various compounds. Cannabinoids have shown efficacy in treating chemotherapy-related nausea and vomiting, poor appetite in advanced HIV, some pain states, and multiple sclerosis-associated spasticity. Recreational cannabinoid use has many known potential serious harms. Physicians should be knowledgeable about cannabinoids and should inquire with their patients about cannabinoid use. Practical suggestions for clinical approaches are included.
KEYWORDS:
cannabinoids; efficacy of cannabinoids; medical marijuana; physician prescribing of cannabinoids; risks of cannabinoids
- PMID: 28861478
- PMCID: PMC5576598
- DOI: 10.1089/can.2015.0010
Conflict of interest statement
No competing financial interests exist.